General Information
As of 05/25/2012
|
| NAV |
$30.43 |
| NAV Daily Change |
$0.06 |
| % Yield |
0 |
| % SEC Yield |
N/A |
| % YTD Return (as of 04/30/2012) |
9.44 |
| Objective* |
Equity - Sector Health |
| Peer* |
HL LG |
* Key
Portfolio Statistics
|
| % Unrealized Gain YTD |
10.69 |
| Net Assets (Mil $) N/A |
947.20 |
| % Turnover N/A |
135.00 |
Fees
|
| % Max Sales Load |
5.25 |
| % Min Sales Load |
.00 |
| % Max Deferred Load |
.00 |
Expenses
|
| % Max 12b-1 Fee |
.25 |
| % Max Management Fee |
.74 |
| % Redemption Fee |
.00 |
| % Expense Ratio |
1.31 |
Allocation
|
| Large Growth |
19.71 |
| Large Value |
.00 |
| Small Growth |
.00 |
| Small Value |
17.64 |
| Foreign Stock |
.00 |
| Emerging Market |
.00 |
| Precious Metals |
.00 |
| Intermediate Bond |
.00 |
| Foreign Bond |
25.89 |
| High Yield Bond |
16.69 |
Portfolio Information |
| Composition |
| As of N/A |
% of Net Assets |
| Stock |
96.00 |
| Cash |
7.06 |
| Bonds |
.00 |
| Preferred |
.00 |
| Convertibles |
.00 |
| Foreign Stock |
9.01 |
| Foreign Bonds |
.00 |
| Hedge |
.00 |
| Other |
-3.05 |
Sector / Country Weightings
|
| As of 12/31/2011 |
% of Portfolio |
| Health |
58.03 |
| Industrial Cyclical |
11.47 |
| Retail Trade |
8.38 |
| Finance |
8.25 |
| Other |
4.51 |
| Services |
4.51 |
| Technology |
3.36 |
| Non-Durable |
1.49 |
| N/A |
N/A |
Portfolio Holdings |
Top Equity Holdings
(As of 12/31/2011) |
% of Portfolio |
Value (Mil$) |
|
| PFIZER INC |
5.66 |
93.81 |
| BRISTOL MYERS SQUIBB CO |
4.15 |
68.73 |
| ROCHE HOLDING AG |
3.88 |
64.37 |
| AMGEN INC |
3.58 |
59.37 |
| JOHNSON + JOHNSON |
3.53 |
58.57 |
| MERCK + CO. INC. |
3.34 |
55.32 |
| BIOGEN IDEC INC |
3.28 |
54.33 |
| GLAXOSMITHKLINE PLC ADR |
3.03 |
50.17 |
| MEDTRONIC INC |
2.58 |
42.83 |
| N/A |
N/A |
N/A |
|
|
This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Funds over the next 6 months.
| Zacks Rank |
Definition |
| #1 |
Strong Buy |
| #2 |
Buy |
| #3 |
Hold |
| #4 |
Sell |
| #5 |
Strong Sell |
| S&P |
500 |
Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank
Zacks Premium Research
|
Zacks Mutual Fund Rank
|
| |
Find similar funds that have a Mutual Fund Rank.
Find Similar Funds Now  |
Fund Description
|
The fund was incepted in December 1999 and is managed by State Street Research & Management Company. The fund seeks to provide long-term growth of capital. The fund is a sector fund that invests primarily in healthcare stocks of the Russell 3000 Index or in similar companies, including foreign companies. While focused on the healthcare sector, it invests in a variety of different companies within this sector, including pharmaceutical, biotechnology, medical devices and healthcare services companies. Under normal market conditions, the fund invests at least 80% of its total assets in securities of companies in health sciences and related industries. The fund's investments may include common and preferred stocks, convertible securities, warrants and depository receipts. The fund reserves the right to invest up to 20% of its total assets in other securities. These may include stocks of companies not associated with health sciences. The fund typically distributes its net income and net capital gains, if any, around the end of the fund's fiscal year, which is February 28. To comply with tax regulations, the fund may be required to pay an additional income dividend or capital gains distribution in December.
|
Stock Holding Statistics
% of Net Assets
|
| As Of |
N/A |
| Total Issues |
80 |
| Avg. P/E |
26.34 |
| Avg. P/Book |
4.94 |
| Avg. EPS Growth |
14.94 |
| Avg. Market Value (Mil $) |
48,490 |
Risk
|
|
3 Year |
5 Year |
10 Year |
| Beta |
0.67 |
0.64 |
0.00 |
| Alpha |
4.40 |
5.57 |
0.00 |
| R Squared |
0.72 |
0.68 |
0.00 |
| Std. Dev. |
12.39 |
14.75 |
0.00 |
| Sharpe |
1.49 |
0.40 |
0.00 |
Shareholder Information
|
| Manager |
Erin Xie |
| Since |
07/03 |
| Manager Rating * SEE EXPLANTION |
5.2 |
| Inception Date |
10/28/2002 |
| Shareholders |
0 |
| Dividends Paid |
A |
| Minimum Initial Investment |
$1,000 |
| Minimum Subsequent Investment |
$50 |
| IRA Minimum |
$100 |
| IRA Available |
Y |
Check Writing |
N |
Phone Invest |
Y |
| Phone Exchange |
Y |
Phone Redeem |
Y |
Auto Invest |
Y |
| Wire Redeem |
Y |
Wire Fee |
Y |
Wire Transfer |
Y |
Contact Information
|
| Family |
BlackRock |
| Address |
40 East 52nd Street
New York, NY 10022 |
| Phone |
800 441-7762 |
|
Sponsored Links 
